Association Between Low Serum Testosterone and the Development of Metabolic Syndrome in Elderly Taiwanese Men

References

• Davidiuk AJ , Broderick GA . Adult-onset hypogonadism: evaluation and role of testosterone replacement therapy. Transl Androl Urol . 2016;5(6):824. doi:10.21037/tau.2016.09.02 28078213
   PubMed Web of Science ®Google Scholar
• Khera M, Broderick GA, Carson III CC, et al. Adult-onset hypogonadism. Mayo Clinic Proceedings; Elsevier. 2016;91(7). doi:10.1016/j.mayocp.2016.04.022
   Google Scholar
• Mulligan T , Frick M , Zuraw Q , Stemhagen A , McWhirter C . Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract . 2008;60(7):762–769. doi:10.1111/j.1742-1241.2006.00992.x
   Web of Science ®Google Scholar
• Araujo AB , Esche GR , Kupelian V , et al. Prevalence of symptomatic androgen deficiency in men. J Clin Endocrinol Metab . 2007;92(11):4241–4247. doi:10.1210/jc.2007-1245 17698901
   PubMed Web of Science ®Google Scholar
• Wu FC , Tajar A , Pye SR , et al. Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. J Clin Endocrinol Metab . 2008;93(7):2737–2745. doi:10.1210/jc.2007-1972 18270261
   PubMed Web of Science ®Google Scholar
• Le TN , Nestler JE , Strauss III JF , Wickham III EP . Sex hormone-binding globulin and type 2 diabetes mellitus. Trends Endocrinol Metab . 2012;23(1):32–40. doi:10.1016/j.tem.2011.09.005 22047952
   PubMed Web of Science ®Google Scholar
• Tint AN , Hoermann R , Wong H , et al. Association of sex hormone-binding globulin and free testosterone with mortality in men with type 2 diabetes mellitus. Eur J Endocrinol . 2016;174(1):59–68. doi:10.1530/EJE-15-0672 26483395
   PubMed Web of Science ®Google Scholar
• Park Y-W , Zhu S , Palaniappan L , Heshka S , Carnethon MR , Heymsfield SB . The metabolic syndrome: prevalence and associated risk factor findings in the US population from the third national health and nutrition examination survey, 1988–1994. Arch Intern Med . 2003;163(4):427–436. doi:10.1001/archinte.163.4.427 12588201
   PubMedGoogle Scholar
• Aguilar M , Bhuket T , Torres S , Liu B , Wong RJ . Prevalence of the metabolic syndrome in the United States, 2003–2012. JAMA . 2015;313(19):1973–1974. doi:10.1001/jama.2015.4260 25988468
   PubMed Web of Science ®Google Scholar
• Bhasin S , Brito JP , Cunningham GR , et al. Testosterone therapy in men with hypogonadism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab . 2018;103(5):1715–1744. doi:10.1210/jc.2018-00229 29562364
   PubMed Web of Science ®Google Scholar
• Kelly DM , Jones TH . Testosterone: a metabolic hormone in health and disease. J Endocrinol . 2013;217(3):R25–45. doi:10.1530/JOE-12-0455 23378050
   PubMed Web of Science ®Google Scholar
• Cunningham GR . Testosterone and metabolic syndrome. Asian J Androl . 2015;17(2):192. doi:10.4103/1008-682X.148068 25652634
   PubMed Web of Science ®Google Scholar
• Harada N . Role of androgens in energy metabolism affecting on body composition, metabolic syndrome, type 2 diabetes, cardiovascular disease, and longevity: lessons from a meta-analysis and rodent studies. Biosci Biotechnol Biochem . 2018;82(10):1667–1682. doi:10.1080/09168451.2018.1490172 29957125
   PubMed Web of Science ®Google Scholar
• Corona G , Rastrelli G , Maggi M . Diagnosis and treatment of late-onset hypogonadism: systematic review and meta-analysis of TRT outcomes. Best Pract Res Clin Endocrinol Metab . 2013;27(4):557–579. doi:10.1016/j.beem.2013.05.002 24054931
   PubMed Web of Science ®Google Scholar
• Wan Z-H , Wen Y-B , Ding Q-F , Xu T-Y . Effects of testosterone substitution on metabolic syndrome-related factors in hypogonadal males: a meta-analysis. Zhonghua Nan Ke Xue . 2010;16(6):510–515.20608354
   PubMedGoogle Scholar
• Grossmann M , Hoermann R , Wittert G , Yeap BB . Effects of testosterone treatment on glucose metabolism and symptoms in men with type 2 diabetes and the metabolic syndrome: a systematic review and meta‐analysis of randomized controlled clinical trials. Clin Endocrinol (Oxf) . 2015;83(3):344–351. doi:10.1111/cen.12664 25557752
   PubMed Web of Science ®Google Scholar
• Qaseem A , Horwitch CA , Vijan S , Etxeandia-Ikobaltzeta I , Kansagara D . Testosterone treatment in adult men with age-related low testosterone: a clinical guideline from the American College of Physicians. Ann Intern Med . 2020;172(2):126–133. doi:10.7326/M19-0882 31905405
   PubMed Web of Science ®Google Scholar
• Wu X , Tsai SP , Tsao CK , et al. Cohort profile: the Taiwan MJ Cohort: half a million Chinese with repeated health surveillance data. Int J Epidemiol . 2017;46(6):1744–1744g. doi:10.1093/ije/dyw282 28204597
   PubMed Web of Science ®Google Scholar
• Grundy SM , Cleeman JI , Daniels SR , et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation . 2005;112(17):2735–2752. doi:10.1161/CIRCULATIONAHA.105.169404 16157765
   PubMed Web of Science ®Google Scholar
• Harman SM , Metter EJ , Tobin JD , Pearson J , Blackman MR . Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J Clin Endocrinol Metab . 2001;86(2):724–731. doi:10.1210/jcem.86.2.7219 11158037
   PubMed Web of Science ®Google Scholar
• DeFronzo RA , Ferrannini E . Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care . 1991;14(3):173–194. doi:10.2337/diacare.14.3.173 2044434
   PubMed Web of Science ®Google Scholar
• Traish AM , Saad F , Guay A . The dark side of testosterone deficiency: II. Type 2 diabetes and insulin resistance. J Androl . 2008;30(1):23–32. doi:10.2164/jandrol.108.005751 18772488
   PubMedGoogle Scholar
• Basaria S , Muller DC , Carducci MA , Egan J , Dobs AS . Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen‐deprivation therapy. Cancer . 2006;106(3):581–588. doi:10.1002/cncr.21642 16388523
   PubMed Web of Science ®Google Scholar
• Morimoto S , Mendoza-Rodriguez C , Hiriart M , Larrieta M , Vital P , Cerbon M . Protective effect of testosterone on early apoptotic damage induced by streptozotocin in rat pancreas. J Endocrinol . 2005;187(2):217–224. doi:10.1677/joe.1.06357 16293769
   PubMed Web of Science ®Google Scholar
• Dhindsa S , Ghanim H , Batra M , et al. Insulin resistance and inflammation in hypogonadotropic hypogonadism and their reduction after testosterone replacement in men with type 2 diabetes. Diabetes Care . 2016;39(1):82–91. doi:10.2337/dc15-1518 26622051
   PubMed Web of Science ®Google Scholar
• Laaksonen DE , Niskanen L , Punnonen K , et al. Testosterone and sex hormone–binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care . 2004;27(5):1036–1041. doi:10.2337/diacare.27.5.1036 15111517
   PubMed Web of Science ®Google Scholar
• Gevi F , Fanelli G , Zolla L . Metabolic patterns in insulin-resistant male hypogonadism. Cell Death Dis . 2018;9(6):1–11. doi:10.1038/s41419-018-0587-9 29298988
   PubMed Web of Science ®Google Scholar
• Glass AR , Swerdloff RS , Bray GA , Dahms WT , Atkinson RL . Low serum testosterone and sex-hormone-binding-globulin in massively obese men. J Clin Endocrinol Metab . 1977;45(6):1211–1219. doi:10.1210/jcem-45-6-1211 338622
   PubMed Web of Science ®Google Scholar
• Kaufman JM , Vermeulen A . The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev . 2005;26(6):833–876.15901667
   PubMed Web of Science ®Google Scholar
• Pitteloud N , Hardin M , Dwyer AA , et al. Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men. J Clin Endocrinol Metab . 2005;90(5):2636–2641. doi:10.1210/jc.2004-2190 15713702
   PubMed Web of Science ®Google Scholar
• Saad F , Gooren L . The role of testosterone in the metabolic syndrome: a review. J Steroid Biochem Mol Biol . 2009;114(1–2):40–43. doi:10.1016/j.jsbmb.2008.12.022 19444934
   PubMed Web of Science ®Google Scholar
• Kaukua J , Pekkarinen T , Sane T , Mustajoki P . Sex hormones and sexual function in obese men losing weight. Obes Res . 2003;11(6):689–694. doi:10.1038/oby.2003.98 12805389
   PubMedGoogle Scholar
• Ponce OJ , Spencer-Bonilla G , Alvarez-Villalobos N , et al. The efficacy and adverse events of testosterone replacement therapy in hypogonadal men: a systematic review and meta-analysis of randomized, placebo-controlled trials. J Clin Endocrinol Metab . 2018;103(5):1745–1754. doi:10.1210/jc.2018-00404
   Web of Science ®Google Scholar
• Shores MM . Testosterone treatment and cardiovascular events in prescription database studies. Asian J Androl . 2018;20(2):138. doi:10.4103/aja.aja_25_17 28816202
   PubMed Web of Science ®Google Scholar
• Hackett G . Metabolic effects of testosterone therapy in men with type 2 diabetes and metabolic syndrome. Sex Med Rev . 2019;7(3):476–490. doi:10.1016/j.sxmr.2018.12.004 30803918
   PubMed Web of Science ®Google Scholar
• Corona G , Monami M , Rastrelli G , et al. Testosterone and metabolic syndrome: a meta‐analysis study. J Sex Med . 2011;8(1):272–283. doi:10.1111/j.1743-6109.2010.01991.x 20807333
   PubMed Web of Science ®Google Scholar
• Ramachandran S , Hackett GI , Strange RC . Testosterone replacement therapy: pre‐treatment sex hormone binding globulin levels and age may identify clinical subgroups. Andrology . 2020;8(5):1222–1232. doi:10.1111/andr.12813 32384175
   PubMed Web of Science ®Google Scholar
• Nguyen CP , Hirsch MS , Moeny D , Kaul S , Mohamoud M , Joffe HV . Testosterone and “age-related hypogonadism”—FDA concerns. N Engl J Med . 2015;373(8):689–691. doi:10.1056/NEJMp1506632 26287846
   PubMed Web of Science ®Google Scholar
• Snyder PJ , Bhasin S , Cunningham GR , et al. Effects of testosterone treatment in older men. N Eng J Med . 2016;374(7):611–624. doi:10.1056/NEJMoa1506119
   PubMed Web of Science ®Google Scholar
• Gianatti EJ , Dupuis P , Hoermann R , et al. Effect of testosterone treatment on glucose metabolism in men with type 2 diabetes: a randomized controlled trial. Diabetes Care . 2014;37(8):2098–2107. doi:10.2337/dc13-2845 24804695
   PubMed Web of Science ®Google Scholar
• Mohler III ER , Ellenberg SS , Lewis CE , et al. The effect of testosterone on cardiovascular biomarkers in the testosterone trials. J Clin Endocrinol Metab . 2018;103(2):681–688. doi:10.1210/jc.2017-02243 29253154
   PubMed Web of Science ®Google Scholar
• Crisóstomo L , Pereira SC , Monteiro MP , Raposo JF , Oliveira PF , Alves MG . Lifestyle, metabolic disorders and male hypogonadism–A one-way ticket? Mol Cell Endocrinol . 2020;110945.32707080
   PubMed Web of Science ®Google Scholar
• Livingston M , Downie P , Hackett G , Marrington R , Heald A , Ramachandran S . An audit of the measurement and reporting of male testosterone levels in UK clinical biochemistry laboratories. Int J Clin Pract . 2020;e13607.32649008
   PubMed Web of Science ®Google Scholar